Multiple Myeloma: Monoallelic Deletions of the Tumor Suppressor Genes TP53 and RB1 in Long-Term Follow-Up
- 29 February 2000
- journal article
- Published by Elsevier in Cancer Genetics and Cytogenetics
- Vol. 117 (1), 57-60
- https://doi.org/10.1016/s0165-4608(99)00144-2
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Presence of a p53 Gene Deletion in Patients With Multiple Myeloma Predicts for Short Survival After Conventional-Dose ChemotherapyBlood, 1998
- Multiple Myeloma: Increasing Evidence for a Multistep Transformation ProcessBlood, 1998
- The Retinoblastoma Susceptibility Gene RB-1 in Multiple MyelomaLeukemia & Lymphoma, 1997
- MULTIPLE MYELOMA: ALMOST ALL PATIENTS ARE CYTOGENETICALLY ABNORMALBritish Journal of Haematology, 1996
- High incidence of deletions but infrequent inactivation of the retinoblastoma gene in human myeloma cellsBritish Journal of Haematology, 1995
- Abnormalities of Retinoblastoma Gene Expression in Hematological MalignanciesLeukemia & Lymphoma, 1995
- The Oncoprotein Phenotype of Plasma Cells from Patients with Multiple MyelomaLeukemia & Lymphoma, 1994
- p53 gene mutations in multiple myeloma are associated with advanced forms of malignancyBlood, 1993